FDA Inspection
Solupharm Pharmazeutische Erzeugnisse GmbhSolupharm Pharmazeutische Erzeugnisse Gmbh – FDA Inspection, Jul 29, 2022
Record Details
This FDA Inspection record concerns Solupharm Pharmazeutische Erzeugnisse Gmbh, with an inspection on July 29, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 29, 2022
- Product Type
- Drugs
View Company Profile
ID · 8db235cb-7ffb-47bb-946e-c8ec8bc4830c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1201236
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Solupharm Pharmazeutische Erzeugnisse Gmbh
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 2, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 21, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 22, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Solupharm Pharmazeutische Erzeugnisse Gmbh
- FDA Inspection 1039841 - 2018-02-02
- FDA Inspection 980047 - 2016-06-21
- FDA Inspection 897666 - 2014-09-22
- FDA Inspection 756529 - 2011-11-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.